CONCORD BIOTECH LIMITED Share Price & Technical Analysis
CONCORDBIO · ₹1,339 (-1.06%)
Healthcare / Biotechnology
₹1,339
-1.06%
Concord Biotech Limited, a, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally. It operates through Active Pharmaceutical Ingredients (APIs) and Formulations segments. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other …
Price chart
Seasonality
Oct has 1 positive and 3 negative years (last 4 years shown)
-3% return in Oct, -6% avg return in past 3 year Oct month.
1% return in 2026, 17% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -13% | 7% | -15% | 7% | -9% | 22% | 10% | 0% | -6% | -3% | – | – | 1% |
| 25 | -3% | -27% | 11% | -8% | 15% | 4% | -4% | -4% | -2% | -12% | -2% | -5% | -37% |
| 24 | -1% | -1% | 5% | 7% | -12% | 5% | 6% | 1% | 20% | -10% | 16% | 3% | 38% |
| 23 | – | – | – | – | – | – | – | 8% | 11% | 5% | 16% | 9% | 50% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Concord Biotech Limited, a, biopharma company, engages in the research and development, manufacture, and sale of pharmaceutical products in India and internationally. It operates through Active Pharmaceutical Ingredients (APIs) and Formulations segments. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas. It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, voclosporin, and pimecrolimus for immunosuppressants therapeutic segment; and temsirolimus, everolimus, romidepsin, doxorubicin, mitomycin, midostaurin, and dactinomycin for oncology therapeutic segment. In addition, the company provides mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, daptomycin, fusidic acid, colistimethate sodium, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi acetate, micafungin sodium, and nystatin for anti-fungal therapeutic segment; and lovastatin and pravastatin sodium for other applications. Further, the company provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹140.08B
P/E ratio
46.12
52W high
₹1,615
52W low
₹987.0
Volume
45,381
Beta
0.37
Related stocks in Healthcare
Frequently asked questions
- What is CONCORD BIOTECH LIMITED share price today?
- CONCORD BIOTECH LIMITED (CONCORDBIO) last traded around ₹1,339 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CONCORDBIO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CONCORDBIO. Download the app for real-time alerts.
- How can I analyze CONCORD BIOTECH LIMITED stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.